Company / R&D per Share
OMEROS CORP R&D per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.06
FY2024
5-year range
$1.80 / $2.06
FY2020-FY2024
Trend
+9.6%
vs FY2023
Sector context
#100 of 208
Health Care
What the data says
At $2.06, OMEROS CORP's r&d per share ranks #100 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $1.06 in FY2015 to $2.17 in FY2019.
Based on SEC 10-K filings.
2.06 in FY2024 with a 5-year CAGR of -1.0%.
Improved from $1.80 to $2.06 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +2.6%
- 5-Year CAGR
- -1.0%
- 10-Year CAGR
- -
Sector benchmark
#100 of 208 in Health CareTop 48% of 208This company $2.06 Sector average $12.19
▼
-83.1% below sector average
Key checks
Key Insights
- In FY2024, r&d per share increased 9.6% year-over-year.
- Ranks #100 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.92 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.06 | +9.6% |
| FY2023 | $1.88 | +4.6% |
| FY2022 | $1.80 | -5.7% |
| FY2021 | $1.91 | -4.0% |
| FY2020 | $1.99 | -8.5% |
| FY2019 | $2.17 | +16.4% |
| FY2018 | $1.86 | +46.9% |
| FY2017 | $1.27 | -4.8% |
| FY2016 | $1.33 | +25.5% |
| FY2015 | $1.06 | -32.8% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026